Earlier in Biotech
A multi-omic organoid biobank, derived from tumour samples of 256 patients diagnosed with five distinct types of cancer, was published online on August 5, 2026, in the journal Nature. This comprehensive resource, which includes clinical annotations and matched tumour samples…
Steven Quay, MD, PhD, is reportedly undergoing final vetting for the position of director of the National Institute of Allergy and Infectious Diseases (NIAID), a significant role previously held by Dr. Anthony Fauci for over three decades.
The U.S. Food and Drug Administration (FDA) is anticipated to render a decision regarding the potential approval of the inaugural messenger RNA (mRNA) influenza vaccine. This forthcoming decision represents a pivotal moment in public health, potentially ushering in a new…
Augmental, a startup co-founded by former Neuralink employee Tomás Vega and Corten Singer, has developed the MouthPad, a novel human-computer interface that utilizes tongue movements to control digital devices. Vega, who previously worked at Elon Musk's Neuralink on implantable brain-computer…
The U.S. Food and Drug Administration (FDA) is on the verge of deciding whether to approve the first influenza vaccine that employs messenger RNA (mRNA) technology. This innovative approach mirrors the technology successfully utilized in the COVID-19 vaccines, potentially heralding…
Researchers have published an author correction in the journal Nature on August 3, 2026, detailing significant advancements in the maturation and circuit integration of transplanted human cortical organoids. This correction clarifies and expands upon previous findings regarding the development…
Montana has advanced its plan to become a hub for experimental medical treatments, with new regulations taking effect this week. Biotech companies that have completed preliminary drug testing, which may involve as few as 10 healthy individuals, can now apply…
As of this week, Montana has established a clear pathway for biotech companies to sell experimental drugs directly to consumers. Companies that have completed preliminary testing, which can involve as few as 10 healthy individuals, can now apply…
Mehmet Oz, MD, the Administrator of the Centers for Medicare & Medicaid Services (CMS), reportedly declined an offer to become the Secretary of Health and Human Services (HHS) earlier this year during a White House restructuring of the agency.
Researchers are developing novel biocomputers that utilize brain organoids, clusters of human brain cells grown in vitro, to perform computations. This emerging field, detailed in a publication in Nature on July 27, 2026, presents a significant technological advancement but has…
A groundbreaking gene therapy has demonstrated significant success in treating severe epilepsy in two young boys, according to research published online in Nature on July 24, 2026. The experimental treatment involves switching off one copy of a specific gene…
Researchers have identified and engineered a novel CRISPR-associated enzyme capable of directly shredding the DNA of cancer cells, presenting a potentially groundbreaking new approach to cancer therapy. This enzyme, derived from bacteria, can be precisely directed to target tumor-causing mutations…
Scientists have successfully employed CRISPR gene-editing technology to enhance the efficacy of immunotherapy against prostate cancer in preclinical mouse models. This innovative approach targets specific genetic pathways within cancer cells, making them more visible and vulnerable to the body's own…
CRISPR–Cas systems have been found to transcriptionally regulate diverse innate anti-phage defence systems within bacteria, according to research published online on July 22, 2026, in Nature. These systems utilize CRISPR RNA-like guides to balance antiviral protection with bacterial fitness.
Researchers have developed a novel computational model named ContactSeek that leverages AlphaFold3 to enhance the precision of DNA base editing technologies. This model, detailed in a publication in Nature on July 22, 2026, aims to refine the accuracy of genome…